The Cell & Gene Meeting on the Mesa, scheduled for October 7-9, 2024, at the Arizona Biltmore in Phoenix, AZ, is a key event in the biotech industry. Organized by the Alliance for Regenerative Medicine (ARM), this conference is designed to address the significant challenges and opportunities within the cell and gene therapy sector. The event features expert-led panels, extensive partnering capabilities, exclusive networking opportunities, and over 120 presentations from leading publicly traded and privately held companies in the field.

The conference agenda includes discussions on clinical trial design, alternative payment models, and scale-up and supply chain platforms for advanced therapies. Attendees will benefit from more than 5,000 one-on-one partnering meetings, fostering collaboration and innovation. Notably, the event attracts over 2,100 participants, with more than 20% being C-level executives, providing a unique opportunity for high-level networking and partnership development​.

The Cell & Gene Meeting on the Mesa also emphasizes the commercialization of novel therapies, with sessions focused on managing operating strategies in a volatile funding market, streamlining clinical trial success, and exploring the cell therapy landscape. This blend of strategic discussions and practical workshops ensures that participants gain valuable insights into the latest industry trends and best practices​.